Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹68.3Prev. Close
₹67.03Turnover(Lac.)
₹36.55Day's High
₹68.59Day's Low
₹66.0552 Week's High
₹7952 Week's Low
₹44Book Value
₹11.07Face Value
₹10Mkt Cap (₹ Cr.)
108.8P/E
152.3EPS
0.44Divi. Yield
022 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
24 Aug 2023
12:00 AM
AGM
Announcement Date: 24 Aug, 2023
4 Sep 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 16.27 | 16.27 | 16.27 | 16.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.03 | 0.56 | -0.14 | -1.39 |
Net Worth | 17.3 | 16.83 | 16.13 | 14.88 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 35.75 | 29.69 | 12.36 | 13.45 |
yoy growth (%) | 20.41 | 140.21 | -8.13 | 2.14 |
Raw materials | -32.42 | -25.3 | -9.77 | -8.51 |
As % of sales | 90.7 | 85.24 | 79.05 | 63.25 |
Employee costs | -0.75 | -0.86 | -0.72 | -0.53 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 1.91 | 1.46 | 0.58 | 2.31 |
Depreciation | -0.41 | -0.4 | -0.29 | -0.28 |
Tax paid | -0.67 | -0.25 | -0.11 | -0.51 |
Working capital | 1.16 | 0.5 | 0.52 | 1.66 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 20.41 | 140.21 | -8.13 | 2.14 |
Op profit growth | -12.25 | 95.02 | -64.33 | 200.94 |
EBIT growth | 25.32 | 114.6 | -70.13 | 118.38 |
Net profit growth | 2.83 | 156.46 | -73.76 | 129.25 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,527.5 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,590 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.45 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,110.3 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,440.35 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Ramesh Shah
Non Executive Director
Romil Shah
Independent Director
Shaila Jain
Independent Director
Satish Beohar
Independent Director
Ashok Kumar Ramawat
Whole-time Director
Ketan Shah
Company Sec. & Compli. Officer
Shweta Verma
Independent Director
Gayatri Padiyar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Biofil Chemicals & Pharmaceuticals Ltd
Summary
Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May 92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division.In Feb.96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore. BCPLs new unit was set up at Pithampur in Madhya Pradesh at a project costing Rs 39.75 cr. The Company entered into business partnership with HLL Lifecare Limited (Formerly Hindustan Latex Ltd) an undertaking of Government of India. As per the agreed terms it provided manufacturing facility to HLL Lifecare Limited for manufacturing of Iron and Folic Acid Tablets (IFA) and other Pharmaceuticals products as required by HLL.Presently, the Company is flourishing business activates at Pithampur, in Madhya Pradesh. Now Company is not only dealing in the pharmaceutical product but has diversified its business activity in producing plastic products required f
Read More
What is the Biofil Chemicals & Pharmaceuticals Ltd share price today?
The Biofil Chemicals & Pharmaceuticals Ltd shares price on nse is Rs.₹66.87 today.
What is the Market Cap of Biofil Chemicals & Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Biofil Chemicals & Pharmaceuticals Ltd is ₹108.80 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Biofil Chemicals & Pharmaceuticals Ltd?
The PE and PB ratios of Biofil Chemicals & Pharmaceuticals Ltd is 152.3 and 5.99 as of 03 Jul ‘24
What is the 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a Biofil Chemicals & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Biofil Chemicals & Pharmaceuticals Ltd is ₹44 and ₹79 as of 03 Jul ‘24
What is the CAGR of Biofil Chemicals & Pharmaceuticals Ltd?
Biofil Chemicals & Pharmaceuticals Ltd's CAGR for 5 Years at 64.59%, 3 Years at -0.08%, 1 Year at 50.80%, 6 Month at 15.57%, 3 Month at -4.31% and 1 Month at 8.29%.
What is the shareholding pattern of Biofil Chemicals & Pharmaceuticals Ltd?
The shareholding pattern of Biofil Chemicals & Pharmaceuticals Ltd is as follows:
Promoters - 46.82 %
Institutions - 0.11 %
Public - 53.08 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
